NICE Rejects Tecentriq For Small-Cell Lung Cancer In England

Uncertainties Remain Over Long-Term Effectiveness

Lung cancer
NICE has turned down Tecentriq for small-cell lung cancer • Source: Shutterstock

More from United Kingdom

More from Europe